glp-1 medications long term side effects of Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Receptor Agonists: A Multidisciplinary Expert Consensus Comparing GLP‑1 Drugs With Other – The Long-Term Side Effects of

Data presented herein support the notion that prolonged exposure to GLP-1R stimulation can also induce glucose competence by a secondary mechanism involving up-regulation of glycolytic enzymes, and consequently glycolytic flux, arguably the most important stimulus-secretion coupling factor generating pathway in -cells

It is the first in vivo study to systematically evaluate the effects of repeated SNAC exposure on gut microbiota composition, function, and metabolic outcomes

Laboratory Abnormalities Liver Enzymes Increases in alanine aminotransferase (ALT) greater than or equal to 10 times the upper limit of normal were observed in 5 (0.15%) SAXENDA-treated patients (two of whom had ALT greater than 20 and 40 times the upper limit of normal) compared with 1 (0.05%) placebo-treated patient during the SAXENDA clinical trials

They launched that in 2017

Supplementary material The Supplementary Material for this article can be found online at: References 1 CreutzfeldtW

Allignol A, Beyersmann J (2010) Software for fitting nonstandard proportional subdistribution hazards models